1-3 of 3
Imad Al Dakkak
Close
Sort by
Journal Articles

Real-World Analysis of the Underdiagnosis, Clinical Outcomes and Associated Burden of Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy (HSCT-TMA) in the United States of America

Yan Wang, Andrew Rava, Marlene Smuzynski, Bonny Shah, Anusorn Thanataveerat, Imad Al Dakkak, Moh-Lim Ong, Christopher C Dvorak, Vincent Ho
Journal: Blood
Blood (2023) 142 (Supplement 1): 491.
https://doi.org/10.1182/blood-2023-177671
Published: 2023
Journal Articles

Characterization of Patients with aHUS and Triggering/Associated Events, with and without Complement Pathogenic Variants or Anti-Cfh Antibodies: A Global aHUS Registry Analysis

Andrew Siedlecki, Imad Al-Dakkak, Katerina Anokhina, Nicole Isbel, Véronique Frémeaux-Bacchi, Rodney Gilbert, Laurence Greenbaum, Gema Ariceta, Gianluigi Ardissino, Franz Schaefer, Eric Rondeau, Christoph Licht
Journal: Blood
Blood (2022) 140 (Supplement 1): 2767–2769.
https://doi.org/10.1182/blood-2022-155814
Published: 2022
Journal Articles

Real-World Patient Characteristics, Treatment Patterns and Outcomes for Patients with Atypical Hemolytic Uremic Syndrome Who Have Switched from Eculizumab to Ravulizumab in the USA

Yan Wang, Imad Al-Dakkak, Katherine Garlo, Moh-Lim Ong, Ioannis Tomazos, Arash Mahajerin
Journal: Blood
Blood (2021) 138 (Supplement 1): 5003.
https://doi.org/10.1182/blood-2021-152598
Published: 2021